Company patents
Antares Pharma, Inc.
Antares Pharma, Inc. demonstrates a strong, albeit fluctuating, commitment to Drug Delivery Devices, which constitutes 84.2% of its portfolio, experiencing a significant 87.5% growth in 2025 after a sharp decline. Surprisingly, despite its medical device focus, the company also maintains a substantial 43.9% of its portfolio in Pharmaceutical Preparations, which saw a 40.0% growth in 2024, indicating a dual strategy in both device innovation and pharmaceutical formulation, with Therapeutic Activity (Pharma) emerging as a renewed focus with 2 patents so far in 2026 after a complete drop in 2025.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
57 US filings (since 2023) · 3 categories · 2 themes
Mechanical or electromechanical systems designed for precise, often self-administered, delivery of medicaments, including features for dose setting, needle insertion/retraction, and safety mechanisms to prevent premature activation.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Patents
Showing 1-10 of 85